Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


Recent & Breaking News (TSX:EDT)

Spectral Expands its Renal Replacement Therapy Development Program to Include the Home Dialysis Market

GlobeNewswire March 20, 2019

Spectral Announces First Orders of Its Proprietary CRRT Machine

GlobeNewswire February 21, 2019

Spectral Announces Approval of Tigris Trial by the US FDA

GlobeNewswire February 19, 2019

Spectral Announces Distribution Agreement for its Proprietary CRRT Machine

GlobeNewswire January 22, 2019

Spectral to Attend the 37th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 19, 2018

Spectral Announces Results of a Face-to-Face meeting with the U.S. FDA

GlobeNewswire December 17, 2018

Spectral Announces Publication of the post hoc analysis of EUPHRATES trial in Intensive Care Medicine

GlobeNewswire November 26, 2018

Spectral Announces Third Quarter Results

GlobeNewswire November 14, 2018

Spectral to enhance the Sales and Marketing team in Canada

GlobeNewswire October 31, 2018

Spectral Announces Presentation at the European Society of Intensive Care Medicine Oct 22nd and Publication of Overall Results of the EUPHRATES trial in JAMA

GlobeNewswire October 18, 2018

Spectral Enters into Technology Transfer Transaction And Provides Update on US FDA Process

GlobeNewswire October 1, 2018

Spectral Announces Second Quarter Results

GlobeNewswire August 14, 2018

Spectral Announces Successful Manufacturing Audit of Toray by the US FDA

GlobeNewswire July 18, 2018

Spectral Announces Voting Results of Annual Meeting

GlobeNewswire June 7, 2018

Spectral Provides Corporate Update

GlobeNewswire May 30, 2018

Spectral Announces First Quarter Results

GlobeNewswire May 11, 2018

Spectral Announces Fourth Quarter and Fiscal 2017 Results

GlobeNewswire March 29, 2018

US Food and Drug Administration (FDA) provides communication to Spectral  

GlobeNewswire March 19, 2018

Spectral Announces Health Canada Approval of Its Proprietary Stand-Alone Pump for CRRT and Hemoperfusion

GlobeNewswire February 15, 2018

Spectral Medical Announces the Appointment of Chief Financial Officer

GlobeNewswire February 1, 2018